Brain and other CNS tumors are the most common tumors in children and the second most common in adolescents & young adults. That’s why advancing brain tumor research and supporting families is so critical. 💙.Join us:

The ABTA is proud to partner with the Kidney Cancer Association in the Metastatic Brain Tumor Collaborative. 💜 On September 6, the KCA Virtual Symposium will bring together patients, caregivers, and families to share experiences and strengthen our community through.

Join millions who have switched to Grok.

⏳ The countdown is ON! The ABTA 2025 National Conference starts NEXT WEEK. 📍 Chicago + 🌐 Online | Sept 12–14 . 💜 Learn. Connect. Find hope. Don’t miss the nation’s largest patient-focused brain tumor conference. Register now:

Can’t attend in person? The ABTA 2025 National Conference on Sept 12–14 offers a fully virtual experience bringing groundbreaking research, treatment updates & patient-centered care insights to your screen. Join us from anywhere. Make an impact everywhere. 🔗

Navigating the financial side of a brain tumor diagnosis can be tough. Learn how to understand insurance, reduce costs, and find financial assistance in our latest article. 👉 #BrainTumorStrong #FinancialRelief #HealthInsuranceHelp

📞 Need help navigating brain tumor treatment? Our ABTA CareLine is here to support you for guidance on treatment options, clinical trials, financial resources, and more. Speak with a live person dedicated to helping you on your journey. Call 800-886-ABTA (2282) from 8:30 AM-5

We’re proud to name Dr. Derek Wainwright & Dr. Markus Sieglin as our August Researchers of the Month! 🧠 Their work is driving progress in glioblastoma research—offering new hope to patients & caregivers. Learn more: #Glioblastoma #BrainTumorResearch

“You can feel it here.”.At the ABTA 2025 National Conference, stories are shared, connections are made, and hope comes alive. Sept 12–14 | Chicago & Online.In-person registration ends August 29. Watch the video, then join us:

Headed to the #ABTANationalConference2025? .Don’t miss your chance to join the Passport Challenge, a fun and interactive way to make the most of your in-person experience! . ✅ Visit exhibit booths .✅ Collect stamps along the way .✅ Enter to win exciting prizes . It’s your

Walk. Run. Make a Difference at the Oakland BT5K. Join us Saturday, September 6, at Lake Merritt for the BT5K Northern California. Every step supports life-saving research. Connect with survivors and caregivers, enjoy a scenic 5K, and raise awareness for a cause that matters.

The “Money Matters" session with Aimee Hoch during the #ABTANationalConference2025 can help you manage the financial impact of a brain tumor diagnosis. Register now: . #BrainTumorStrong #BrainTumorAwareness #Connect #BrainCancerSupport #BrainTumor

Some conversations are hard, but necessary. Join us in person or online at #ABTANationalConference2025 for: .Difficult Conversations: Decision-Making & Communication .📅 Sat, Sept. 13 | 🕐 1:15 PM CDT |📍 Chicago + virtual / online . 💬 Learn to navigate tough talks after a

We’re honored to name Larry Berg as the 2025 Juliana Schafer Spirit of Hope Award winner! 🎉.Larry turned personal tragedy into a mission—raising $1.7M+, building partnerships, and honoring his daughter Kaitlyn’s legacy with a $175K research gift. 💙 . #MeetHopeHeadOn

BREAKING: The FDA has approved Modeyso™ (dordaviprone), the first drug for diffuse midline glioma (DIPG) with the H3 K27M mutation. DMG/DIPG is a rare and aggressive brain tumor that mostly affects children and young adults. This is a long-awaited step forward for a devastating

💡 Every new brain tumor treatment starts with a bold idea—and a clinical trial. From the lab to FDA approval, vorasidenib’s journey shows how research becomes real hope for patients with IDH-mutant low-grade gliomas. ✨ Learn how clinical trials bring new treatments to

@StanfordNsurg @StanfordBrainTC.

🧠 Personalized medicine is changing #braintumor care. 🔬 Learn how molecular profiling + immunotherapy are shaping the future of treatment at the #ABTANationalConference2025 . Join us virtually or in-person Sept. 14 for this powerful session with @MichaelLimMD of @StanfordMed.